Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Affamed, Bharat, Biocardia, Direct, Glenmark, Henlius, Innovent, Inxmed, Medilink, Novavax, Ocugen, Paradigm, Recbio, Regeneron, Serum Institute, Vistagen.